尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Ballintyn Rhonda Germany, 董事. Director active across 3 companies, notably Integra Lifesciences Holdings CORP. In total, 3 reports have been logged. Activity tracked since 14 May 2021. The latest transaction was filed on 1 August 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Rhonda Germany Ballintyn serves as a Board Member at Integra Lifesciences Holdings Corp and Aegion Corp. She has significant experience in the health and infrastructure sectors. As a board member, Rhonda contributes to the strategic direction of the companies, ensuring regulatory compliance and innovation. Her expertise is essential in guiding strategic decisions.